Clinical Trial Update: Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

View source ↗

Summary

A clinical trial designed to prospectively define subtypes of metastatic pancreatic ductal adenocarcinoma using comprehensive genomic analysis; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Cancer, Pancreatic Cancer | Status: RECRUITING